BRCA1 is essential for HR, and since HR deficiency promotes the toxicity of PARPi, the effect of PARPi is maximized in BRCA1-mutated, HR-deficient cancers (Lord et al. 2015). The gene discussed is BRCA1; the disease is cancer.